Pharma and Medical Devices Pricing & Reimbursement in the CEE (BALS79)

Venue: Vienna

Location: Vienna, Austria, Austria

Event Date/Time: Jun 16, 2009 End Date/Time: Jun 17, 2009
Registration Date: Jun 01, 2009
Early Registration Date: Apr 10, 2009
Report as Spam

Description

Event summary:
Pricing and reimbursement processes in CEE region are changing rapidly since no single European pricing system exists. On the other hand, national price control authorities use different approaches for setting the price of a drug in their market. This is why Pharma and Medical Devices companies need to have effective pricing strategies and excel in negotiation.

Join us in Vienna to take part in case studies, panel discussions and networking that will give you an interactive learning opportunity. You will find out more about P&R systems in CEE countries, the challenge of reference pricing system, impact of EU integration on P&R processes, cost containment measures and lot more!

Expert Advisory Board:
Boehringer-Ingelheim, Poland, Market Access Director
Amgen GmbH, Austria, Executive Medical Director Eastern Europe
Astrazeneca, Czech Republic, Medical Marketing Director, Market Access CEE

Key Speakers:
General Health Insurance Company, Slovakia, Board Member, Director for Strategy & Health Policies
Public Policy and Management, Unit of Health Economics and Technology Assessment, Corvinus University, Hungary, Associate Professor
Ministry of Health, Poland, Head of Reimbursement Unit, Drug Policy and Pharmacy Department
Merck Sharp & Dohme, Belgium, Director European Union Affairs
Amgen GmbH, Austria, Executive Medical Director Eastern Europe
Astrazeneca, Czech Republic, Medical Marketing Director, Market Access CEE
Medtronic, Switzerland, Director, Reimbursement and Health Economics, CEE

Key Topics:
- Explore how to optimize spends on drugs with General Health Insurance Company, Slovakia
Understand how can EU legislation influence the evolution in Pricing & Reimbursement with Merck Sharp & Dohme
- Get insight on the role of HTA in the new EU member states during the economic recession by Corvinus University
- Enhance the value of vaccines as GSK Biologicals did
Learn from Astrazeneca how to ensure cost effectiveness and success in the market

Venue

Vienna
Vienna
Austria
Austria
MORE INFO ON THIS VENUE

Additional Information

Group descounts available.

Types